Instead of continuing full therapeutic doses, many patients transition to lower or maintenance doses under medical supervision
Endocrine Reviews, 43(5), 763793
Results require continued use of medication along with lifestyle modifications including reduced caloric intake and increased physical activity
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 49 peptides to reveal personal predispositions related to appetite signaling, weight regulation, and nutrient utilization
The primary focus of human studies lies in overall body weight and overall metabolic indicators
True non-responders: uncertain outcomes If semaglutide produced absolutely no appetite suppression, no metabolic improvement, and no weight loss even at the maximum 2.4mg dose over 16 or more weeks, you may have fundamental resistance to GLP-1 receptor agonism